CLASS II Drug recall · Reported 10 Mar 2021 · FDA Enforcement Report

Metoclopramide Injection USP, 10 mg/ (5 mg/mL) recalled

Teva Pharmaceuticals USA is recalling Metoclopramide Injection USP, 10 mg/ (5 mg/mL), 25x2mL Single Dose Vials kits, distributed nationwide in the US. The recall was initiated on 15 Feb 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 31325335B, exp. date 07/2021
NDC0703-4502
Quantity recalled9,452 cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0297-2021
FDA event ID
87330
Recalling firm
Teva Pharmaceuticals USA, Parsippany, NJ
Manufacturer
Teva Parenteral Medicines, Inc.
Classification
Class II
Status
Terminated
Recall initiated
15 Feb 2021
FDA classified
3 Mar 2021
Reported
10 Mar 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

15 Feb 2021Recall initiated by company
3 Mar 2021Classified by FDA+16 days
10 Mar 2021Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Chemical contamination; Unknown brown residue adhering to the inside of one vial.

Product as listed by the FDA

Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only, Distributed by Teva Pharmaceuticals, USA, Inc., Parsippany, NJ Vial NDC 0703-4502-01 (vial) NDC# 0703-4502-04 (tray)

Where it was distributed

Nationwide, including Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Chemical contamination; Unknown brown residue adhering to the inside of one vial.

Which lots are affected?

Lot # 31325335B, exp. date 07/2021

Where was it sold?

Nationwide, including Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Teva Pharmaceuticals USA

All 280

Other Metoclopramide recalls

All 12